Mount Sinai Researchers Identify Blood RNA Biomarkers for Alzheimer’s Detection
The study highlights the role of brain-derived nanoparticles in identifying the disease through minimally invasive testing.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
Alzheimer’s Blood-Based Biomarker Testing Integrated into Clinical Workflows
Lucent Diagnostics and Tempus AI have partnered to integrate blood-based Alzheimer’s biomarker testing into clinical workflows, aiming to expand access and improve detection accuracy for neurologists.
Dementias & Alzheimer’s
Latest
Gut-Derived Blood Markers May Detect Early Cognitive Decline Before Symptoms
Researchers at the University of East Anglia report that gut-derived blood markers may help detect early cognitive decline before symptoms, according to findings published in Gut Microbes.
Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
The test identifies carriers of a genetic variant found in up to 60% of Alzheimer’s patients, helping clinicians triage patients and guide treatment decisions.
Read More
Blood Test ‘Clock’ Predicts Alzheimer’s Symptom Onset Within Years
Washington University researchers have developed a blood test using p-tau217 protein levels to predict Alzheimer’s symptom onset within three to four years.
Read More
Lucent Diagnostics Partners to Bring Blood-Based Alzheimer’s Testing to Community Settings
The collaboration will expand access to Alzheimer’s biomarker testing through mobile delivery to community centers, churches, and senior centers nationwide.
Read More
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test
The test uses five biomarkers and proprietary technology to detect amyloid brain plaques in patients with cognitive symptoms.
Read More
FDA-Cleared Blood Test for Alzheimer’s Assessment in Primary Care Now Available Nationwide
The Elecsys pTau-181 test helps primary care clinicians rule out Alzheimer’s disease in symptomatic patients aged 55 and older.
Read More
Circular Genomics Secures Exclusive Rights to Blood Test Technology for Alzheimer’s Disease
Circular Genomics has secured exclusive rights from Washington University and Max Delbrück Center to develop a blood-based Alzheimer’s test using circular RNA biomarkers.
Read More
Finger Prick Blood Test for Alzheimer’s Diagnosis Enters Large-Scale Trial
A large-scale international trial is evaluating a finger prick blood test for Alzheimer’s, analyzing three protein biomarkers as a potential alternative to PET scans and lumbar punctures.
Read More
Study Links Fat Transport Molecules to Alzheimer’s Risk Based on Genetics
Research finds lysophosphatidylcholines either promote or protect against disease depending on APOE ε4 gene status, with implications for personalized treatments.
Read More
ALZpath Blood Test Enables Large-Scale Alzheimer’s Disease Study
Study using pTau217 assay finds more than one in 10 adults over age 70 may be eligible for treatments to slow cognitive decline.
Read More
ALZpath, Siemens Healthineers Partner on Blood-Based Alzheimer’s Testing
Licensing agreement will integrate ALZpath’s pTau217 antibody into Siemens’ Atellica analyzer test menu for IVD Alzheimer’s diagnostics.
Read More
Blood Test Shows Obesity Speeds Alzheimer’s Development
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity’s impact on Alzheimer’s pathology.
Read More
Plasma pTau Shows Promise as Early Endpoint in Alzheimer’s Trials
New cross-trial analysis supports the biomarker’s potential to predict clinical benefit, reinforcing biomarker-driven trial designs.
Read More
Circular Genomics Raises $15M to Advance Circular RNA Platform for Alzheimer’s Detection
The financing will accelerate clinical validation and commercial readiness of brain-derived blood biomarkers based on circular RNA technology.
Read More
Neurogen Biomarking Partners with Tasso for Needle-Free Blood Collection in Alzheimer’s Testing
The collaboration aims to make home-based Alzheimer’s biomarker testing more accessible through virtually painless blood collection technology.
Read More
Digital Cognitive Test Helps Identify Primary Care Patients Who Need Alzheimer’s Blood Biomarker Testing
Researchers say the digital assessment improves early identification of patients likely to benefit from blood biomarker testing for Alzheimer’s disease.
Read More